PPCB
Price:
$0.0003
Market Cap:
$206.41K
Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug discovery program. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.[Read more]
Industry
Biotechnology
IPO Date
2012-11-12
Stock Exchange
PNK
Ticker
PPCB
According to Propanc Biopharma, Inc.’s latest financial reports and current stock price. The company's current ROE is 57.26%. This represents a change of 295.74% compared to the average of 14.47% of the last 4 quarters.
The mean historical ROE of Propanc Biopharma, Inc. over the last ten years is 133.01%. The current 57.26% ROE has changed -56.95% with respect to the historical average. Over the past ten years (40 quarters), PPCB's ROE was at its highest in in the June 2016 quarter at 111.39%. The ROE was at its lowest in in the June 2020 quarter at -32.95%.
Average
133.01%
Median
111.44%
Minimum
48.17%
Maximum
366.83%
Discovering the peaks and valleys of Propanc Biopharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 228.22%
Maximum Annual ROE = 366.83%
Minimum Annual Increase = -60.59%
Minimum Annual ROE = 48.17%
Year | ROE | Change |
---|---|---|
2024 | 48.17% | -52.02% |
2023 | 100.41% | -9.64% |
2022 | 111.12% | 40.86% |
2021 | 78.89% | -39.39% |
2020 | 130.17% | -2.80% |
2019 | 133.91% | 28.45% |
2018 | 104.25% | -27.89% |
2017 | 144.58% | -60.59% |
2016 | 366.83% | 228.22% |
2015 | 111.76% | 89.74% |
The current ROE of Propanc Biopharma, Inc. (PPCB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
86.57%
5-year avg
93.75%
10-year avg
133.01%
Propanc Biopharma, Inc.’s ROE is less than Ocean Biomedical, Inc. (64.85%), greater than Enveric Biosciences, Inc. (-234.16%), greater than Hepion Pharmaceuticals, Inc. (-328.66%), greater than Elevation Oncology, Inc. (-57.97%), less than AVROBIO, Inc. (29.68%), greater than CohBar, Inc. (-58.44%), greater than Zura Bio Limited (-35.45%), greater than CureVac N.V. (-56.93%), less than Reata Pharmaceuticals, Inc. (19.32%), less than Krystal Biotech, Inc. (6.34%), greater than Vir Biotechnology, Inc. (-36.71%),
Company | ROE | Market cap |
---|---|---|
64.85% | $31.18M | |
-234.16% | $4.14M | |
-328.66% | $3.68M | |
-57.97% | $30.89M | |
29.68% | $5.24M | |
-58.44% | $1.42M | |
-35.45% | $278.69M | |
-56.93% | $607.87M | |
19.32% | $6.57B | |
6.34% | $4.91B | |
-36.71% | $1.28B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Propanc Biopharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Propanc Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Propanc Biopharma, Inc.'s ROE?
How is the ROE calculated for Propanc Biopharma, Inc. (PPCB)?
What is the highest ROE for Propanc Biopharma, Inc. (PPCB)?
What is the 3-year average ROE for Propanc Biopharma, Inc. (PPCB)?
What is the 5-year average ROE for Propanc Biopharma, Inc. (PPCB)?
How does the current ROE for Propanc Biopharma, Inc. (PPCB) compare to its historical average?